Works matching DE "AFLIBERCEPT"

Results: 364
    1
    2
    3

    Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 3, p. 1131, doi. 10.1007/s00432-022-03946-x
    By:
    • Beom, Seung-Hoon;
    • Kim, Jong Gwang;
    • Baik, Seung Hyuk;
    • Shin, Seong Hoon;
    • Park, Inkeun;
    • Park, Young Suk;
    • Lee, Myung-Ah;
    • Lee, Soohyeon;
    • Jeon, So-Yeon;
    • Han, Sae-Won;
    • Kang, Myoung Hee;
    • Oh, Jisu;
    • Kim, Jin Soo;
    • Kim, Jin Young;
    • Ahn, Mi Sun;
    • Zang, Dae Young;
    • Bae, Byung-Noe;
    • Jo, Hong Jae;
    • Kim, Hee Kyung;
    • Kim, Jung-Han
    Publication type:
    Article
    4
    5

    Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 12, p. 1497, doi. 10.1093/jnci/djad120
    By:
    • Pesántez, David;
    • Hoorn, Sanne ten;
    • Machado, Isidro;
    • García-Albéniz, Xabier;
    • Rodríguez-Salas, Nuria;
    • Heredia-Soto, Victoria;
    • Viñal, David;
    • Pericay, Carles;
    • García-Carbonero, Rocio;
    • Losa, Ferran;
    • Alonso, Vicente;
    • Vera, Ruth;
    • Batlle, Jaime Feliu;
    • Gallego, Javier;
    • Salud, Antonieta;
    • Nogué, Miquel;
    • Layos, Laura;
    • Montagut, Clara;
    • Capdevila, Jaume;
    • Vermeulen, Louis
    Publication type:
    Article
    6
    7
    8
    9

    Efficacy and Safety of Intravitreal Aflibercept Treat and Extend for Polypoidal Choroidal Vasculopathy in the ATLANTIC Study: A Randomized Clinical Trial.

    Published in:
    Ophthalmologica, 2022, v. 245, n. 1, p. 80, doi. 10.1159/000518235
    By:
    • Silva, Rufino;
    • Arias, Luis;
    • Nunes, Sandrina;
    • Farinha, Claudia;
    • Coimbra, Rita;
    • Marques, João P.;
    • Cachulo, Maria L.;
    • Figueira, João;
    • Barreto, Patricia;
    • Madeira, Maria H.;
    • Pires, Isabel;
    • Sousa, João C.;
    • Distefano, Laura;
    • Rosa, Paulo;
    • Carneiro, Ângela;
    • Vaz-Pereira, Sara;
    • Meireles, Angelina;
    • Cabrera, Francisco;
    • Bures, Anniken;
    • Mendonça, Luís
    Publication type:
    Article
    10

    Improvements of Retinal Sensitivity after Intravitreal Injection of Aflibercept in Eyes with Neovascular Age-Related Macular Degeneration with or without Polypoidal Choroidal Vasculopathy.

    Published in:
    Ophthalmologica, 2021, v. 244, n. 4, p. 347, doi. 10.1159/000517187
    By:
    • Nizawa, Tomohiro;
    • Kitahashi, Masayasu;
    • Baba, Takayuki;
    • Iwase, Takehito;
    • Kubota-Taniai, Mariko;
    • Hattori, Yoko;
    • Shiko, Yuki;
    • Kawasaki, Yohei;
    • Iwase, Takayuki;
    • Sato, Takatoshi;
    • Ogawa, Shoko;
    • Sugawara, Takeshi;
    • Yamamoto, Shuichi
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Study protocol for HGCSG1801: A multicenter, prospective, phase II trial of second-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer refractory to anti-EGFR antibodies.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.939425
    By:
    • Hiroshi Nakatsumi;
    • Yoshito Komatsu;
    • Tetsuhito Muranaka;
    • Satoshi Yuki;
    • Yasuyuki Kawamoto;
    • Kazuaki Harada;
    • Masayoshi Dazai;
    • Miki Tateyama;
    • Yusuke Sasaki;
    • Takuto Miyagishima;
    • Yasushi Tsuji;
    • Masaki Katagiri;
    • Michio Nakamura;
    • Susumu Sogabe;
    • Kazuteru Hatanaka;
    • Takashi Meguro;
    • Tomoe Kobayashi;
    • Atsushi Ishiguro;
    • Osamu Muto;
    • Yoshiaki Shindo
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Efficacy and Safety of Biosimilar QL1207 vs. the Reference Aflibercept for Patients with Neovascular Age-Related Macular Degeneration: A Randomized Phase 3 Trial.

    Published in:
    Ophthalmology & Therapy, 2024, v. 13, n. 1, p. 353, doi. 10.1007/s40123-023-00836-4
    By:
    • Li, Bing;
    • Fan, Ke;
    • Zhang, Tonghe;
    • Wu, Zhifeng;
    • Zeng, Siming;
    • Zhao, Mingwei;
    • Ren, Qian;
    • Zheng, Dongping;
    • Wang, Lifei;
    • Liu, Xiaoling;
    • Han, Mei;
    • Song, Yanping;
    • Ye, Jian;
    • Pei, Cheng;
    • Yi, Jinglin;
    • Wang, Xian;
    • Peng, Hui;
    • Zhang, Hong;
    • Zhou, Zhanyu;
    • Liang, Xiaoling
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48

    A Review of Aflibercept Treatment for Macular Disease.

    Published in:
    Ophthalmology & Therapy, 2021, v. 10, n. 3, p. 413, doi. 10.1007/s40123-021-00354-1
    By:
    • Anguita, Rodrigo;
    • Tasiopoulou, Anastasia;
    • Shahid, Syed;
    • Roth, Janice;
    • Sim, Sing Yue;
    • Patel, Praveen J.
    Publication type:
    Article
    49
    50